A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Name: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy
Published: 2015
License: Public Domain

AbbVie · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

hepatitis-c hepatitis-c-virus

chronic hepatitis c, hepatitis c virus, hcv, direct-acting antiviral agent (daa)-experienced, hepatitis c, hcv genotype 6, hcv gt1, interferon (ifn) free, hcv genotype 5, hcv gt4, hcv genotype 4, chronic hcv

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 876736
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.